Market Cap: $720.96M
CI
Crescent Biopharma, Inc.
CBIO
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $720.96M
Analysts estimated CBIO earnings of $-0.81 per share this quarter (Q2). CBIO's actual earnings were $-0.74 per share.
CBIO EPS surprise of 8.74%Analysts estimated CBIO earnings of $-0.97 per share this quarter (Q1). CBIO's actual earnings were $-0.70 per share.
CBIO EPS surprise of 27.50%Analysts estimated CBIO earnings of $-2.57 per share this quarter (Q4). CBIO's actual earnings were $-0.54 per share.
CBIO EPS surprise of 78.96%Analysts estimated CBIO earnings of $-2.02 per share this quarter (Q3). CBIO's actual earnings were $-1.27 per share.
CBIO EPS surprise of 37.18%Analysts estimated CBIO earnings of $-1.80 per share this quarter (Q2). CBIO's actual earnings were $-4.93 per share.
CBIO EPS surprise of -174.22%Analysts estimated CBIO earnings of $-5.10 per share this quarter (Q1). CBIO's actual earnings were $-4.00 per share.
CBIO EPS surprise of 21.57%